Sunday, 1 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results

Vivanza Biosciences Financial Results

Vivanza Biosciences reported audited standalone annual revenue of ₹112.34 Crore. The Board also noted resignations of its Director and Company Secretary during the meeting.

Key figures
Value₹112.3 Cr
Source

BSE filing, NSE: VIVANZA. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Vivanza Biosciences Ltd: key numbers

Share price
₹1.54
Market cap
₹6.16 Cr
Revenue (annual)
₹115.9 Cr
Net profit (annual)
₹0.39 Cr
P/E (TTM)
13.6×Sector 45.9×
Promoter holding
20.02%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Vivanza Biosciences Ltd

All →

Other financial results announcements

All →
21:55 IST NSE
Financial ResultsJay Jalaram Technologies Ltd KORE

Jay Jalaram Technologies H1 FY27 Results: Net Profit ₹9.3 Cr, Up 78.8% YoY

Jay Jalaram Technologies Ltd reported revenue from operations of ₹655.8 Cr (+83.7% YoY) and net profit of ₹9.3 Cr (+78.8% YoY) for H1 FY27.

Key figure
Net profit ₹9.3 Cr · +78.8% YoY